Rationale for MYC imaging and targeting in pancreatic cancer

The incidence and lethality of pancreatic ductal adenocarcinoma (PDAC) will continue to increase in the next decade. For most patients, chemotherapeutic combination therapies remain the standard of care. The development and successful implementation of precision oncology in other gastrointestinal tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Günter, Wirth, Matthias, Keller, Ulrich, Saur, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511206/
https://www.ncbi.nlm.nih.gov/pubmed/34637026
http://dx.doi.org/10.1186/s13550-021-00843-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511206/
https://www.ncbi.nlm.nih.gov/pubmed/34637026
http://dx.doi.org/10.1186/s13550-021-00843-1

Ejemplares similares